Delayed referrals, diagnoses undermine cancer patients' faith in health care system
the ONA take:
Analysis of data from a survey conducted by Cancer Research UK scientists revealed that timeliness of referral for cancer tests can have a significant impact on patients’ overall satisfaction with their care and their health care team.
Of the nearly 60,000 survey respondents whose diagnoses were made through their GPs, 23% had been seen three or more times before a referral for cancer tests was given.
Furthermore, these patients were more likely to report negative experiences across 10 of 12 different aspects of their care compared with those patients who were referred after one or two visits with their GPs.
Aspects of care in which patients were dissatisfied included the way they were informed of their diagnosis, how well hospital and GPs worked together to provide care, and confidence and trust in ward nurses.
Although diagnostic delays can be caused by the difficulty in distinguishing cancer symptoms from other diseases and a lack of accurate and easy-to-use tests, the survey results demonstrate the significance of early diagnosis on patients’ overall experience with cancer care.
The researchers report that timeliness of diagnosis is an important factor in patients’ overall experience in their cancer journey.
Timeliness of referral for cancer tests can have a significant impact on patients’ overall satisfaction.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Pediatric Hepatocellular Carcinoma: Challenges and Solutions
- Earlier and Later Adult BMI Associated With Multiple Myeloma Risk
- Cost-Effectiveness of Immunotherapy for Advanced Melanoma Evaluated
- VBPWPs Can Compliment Patient Management in Clinical Trials
- Communication Technology Improves Treatment Burden, Patient Perspective of Oncology Care
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|